News Centre

Nissay Asset Management Issues Nissay S Nippon Semiconductor Equity Index Fund Tracking The Solactive Nippon Semiconductor Opportunity Index

Date 26/08/2024

Solactive is pleased to expand its collaboration with Nissay Asset Management by licensing the Solactive Nippon Semiconductor Opportunity Index. This novel rule-based index tracks the performance of the top Japanese semiconductor-related companies and aims to provide clients with targeted exposure to the whole ecosystem of the semiconductor sector within the Japanese market. The index will serve as the underlying index for the Nissay S Nippon Semiconductor Equity Index Fund and marks the third collaboration between the two firms linked to the highly cost-competitive Nissay S Series.

Thailand Anti-Money Laundering Office, Thailand Securities And Exchange Commission, And Stock Exchange Of Thailand Strengthen Collaboration To Combat Illegal Securities Trading Activities

Date 26/08/2024

The Anti-Money Laundering Office (AMLO), the Securities and Exchange Commission (SEC), and The Stock Exchange of Thailand (SET) have strengthened their collaboration to fight against illegal securities trading activities under the Securities and Exchange Act and the Anti-money Laundering Act. This collaboration aims to dismantle economic criminal activities, particularly those related to securities trading, and to enhance the law enforcement capabilities of each agency as well as their joint operations. These efforts are expected to boost investor confidence in the Thai capital market. Deputy Prime Minister and Minister of Finance Pichai Chunhavajira presided as the honorary witness at the signing ceremony of the Memorandum of Understanding (MOU) for cooperation among the three agencies at the SET building.

Over 20 Innovative Drug Companies On Shanghai Stock Exchange STAR Market Release Interim Reports - More Than Half Show Profit Improvement

Date 26/08/2024

Since August, innovative drug companies listed on the STAR Market have started unveiling their interim reports for 2024. As of the press time on August 26, more than 20 innovative drug companies listed on the STAR Market have released their semi-annual financial data. In the first six months, these businesses collectively reported a total revenue of RMB 28.4 billion, marking a substantial year-on-year increase of 69.21%. The net profit attributed to the parent company amounted to RMB 1.49 billion, shifting from a loss to a profit when compared with the same period last year, with more than half of these companies witnessing improved profitability.

Shanghai Stock Exchange Holds Talk On REITs Investment And Toll Road REITs Valuation

Date 26/08/2024

To help investors better understand the valuation principles behind real estate investment trust (REIT) projects based on toll roads, Shanghai Stock Exchange recently hosted the "REITs Investment Talk" event to discuss the investment value of REITs. Esteemed industry experts from securities companies, public funds, and insurance companies attended the event, along with nearly 100 researchers, investment managers, and other front-line investment professionals joining offline. The event garnered close to 10,000 online views.

Announcing The Launch Of “JPxData Portal (Beta Version)”, A Portal Site Comprehensively Covering Data Provided By JPX Group, Etc.

Date 26/08/2024

Today, JPX Market Innovation & Research, Inc. (hereinafter referred to as “JPXI”) launched “JPxData Portal (beta version)” (hereinafter referred to as “Website”), a portal site that comprehensively introduces data provided by Japan Exchange Group, Japan Exchange Group companies and partner companies (hereinafter referred to as “JPX Group, etc.”).

886 Shanghai Stock Exchange-Listed Companies Disclose Semi-Annual Reports, With 509 Reporting Good Performances

Date 26/08/2024

According to STCN, as of August 26, 886 companies listed on the Shanghai Stock Exchange (SSE) had disclosed their semi-annual performances. Their combined operating revenue reached RMB 7.86 trillion, increasing by 2.3% year on year, and the combined net profit attributable to their parent companies amounted to RMB 679 billion, up 6% year on year. Out of the total, 509 companies reported good performances, representing approximately 60%. The performance growth of 105 companies exceeded 100%, and that of 164 companies surpassed 50%. By sector, numerous pillar industries including non-ferrous metals, transportation, automobile tires, power, and integrated circuits performed well.

Shanghai Stock Exchange: Twenty-Two Innovative Drug Companies On The Star Market Release Semi-Annual Reports, Showcasing A Combined Operating Revenue Of Rmb 28.4 Billion

Date 26/08/2024

So far, 22 innovative drug companies listed on the STAR Market have released their semi-annual performance data, marking that the disclosure process for such companies on the STAR Market is halfway complete. The combined semi-annual operating revenue of these companies reached RMB 28.4 billion, representing a 69.21% increase year on year. The net profit attributable to their parent companies arrived at RMB 1.49 billion, shifting from loss to profit when compared with the same period last year, with more than half of these companies witnessing improved profitability. In general, innovative drug companies listed on the STAR Market are swiftly converting their clinical advantages into industrial benefits and are progressively moving towards commercialization or cashing period of their licensing out both domestically and internationally. Overall, their performance is evidently on an upward trajectory.

SET: mai-listed Companies Post Robust H1/2024 Net Profit

Date 26/08/2024

• Mai-listed firms’ H1 sales up 7.7% y-o-y to THB 104.3 bln
• H1 operating profit up 44.8% y-o-y to THB 8.35 bln
• H1 net profit up 80.5% y-o-y to THB 6.10 bln

SET: Thai Listed Companies Report Continued Earnings Growth In Q2, Propelled By Tourism And Oil-Related Sectors

Date 26/08/2024

• SET-listed firms’ H1 sales up 6.3% y-o-y to THB 8.96 trln
• H1 core operating profit up 18.7% y-o-y to THB 922.74 bln
• H1 net profit up 9.7% y-o-y to THB 519.31 bln

The Saudi Arabia Capital Market Authority Launches The 14th Batch Of The Graduate Development Program

Date 25/08/2024

The Capital Market Authority launches the 14th batch (2024-2025) of the Graduate Development Program (GDP) starting today, August 25, 2024. This comes as part of the CMA's social responsibility initiatives to raise the level of knowledge and skills of graduates in the financial and regulatory aspects of the securities field, enhancing their opportunities to obtain jobs in the capital market sector.